---
figid: PMC3159301__IJE2011-742719.001
figlink: /pmc/articles/PMC3159301/figure/fig1/
number: Figure 1
caption: 'Pathways involved in platelet hyperreactivity in DM patients and therapeutic
  targets. AGE: advanced glycation end products, RAGE: AGE receptors, PKA/B/C: protein
  kinase A/B/C, MAPK: p38 mitogen-activated protein kinase, TK: tyrosine kinase, NO:
  nitric oxide, GC: guanylate cyclase, PAR-1 TR: protease activated receptor; thrombin
  receptor, PI-3: phosphoinositol-3 kinase TRA: thrombin receptor antagonist, TPα:
  thromboxane receptor, TPRA: thromboxane receptor antagonist, and ASA: acetylsalicylic
  acid (aspirin). Increased levels of cAMP lead to platelet inhibition through cAMP-dependent
  protein kinase (PKA) which inhibits signaling though the mitogen-activated protein
  kinases pathway, receptor activation, thromboxane A2 formation, and activation of
  key enzymes such as protein kinase C. The prostaglandin, P2Y, P2X, TR, and TP are
  all seven transmembrane G-protein associated receptors. The TR and TP on the right
  present novel drug targets; their intracellular effectors are omitted for clarity.
  Antiplatelet drugs are shown in red.'
pmcid: PMC3159301
papertitle: 'Platelet Function in Patients with Diabetes Mellitus: From a Theoretical
  to a Practical Perspective.'
reftext: Nicholaos Kakouros, et al. Int J Endocrinol. 2011;2011:742719.
pmc_ranked_result_index: '68394'
pathway_score: 0.9601579
filename: IJE2011-742719.001.jpg
figtitle: Pathways involved in platelet hyperreactivity in DM patients and therapeutic
  targets
year: '2011'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3159301__IJE2011-742719.001.html
  '@type': Dataset
  description: 'Pathways involved in platelet hyperreactivity in DM patients and therapeutic
    targets. AGE: advanced glycation end products, RAGE: AGE receptors, PKA/B/C: protein
    kinase A/B/C, MAPK: p38 mitogen-activated protein kinase, TK: tyrosine kinase,
    NO: nitric oxide, GC: guanylate cyclase, PAR-1 TR: protease activated receptor;
    thrombin receptor, PI-3: phosphoinositol-3 kinase TRA: thrombin receptor antagonist,
    TPα: thromboxane receptor, TPRA: thromboxane receptor antagonist, and ASA: acetylsalicylic
    acid (aspirin). Increased levels of cAMP lead to platelet inhibition through cAMP-dependent
    protein kinase (PKA) which inhibits signaling though the mitogen-activated protein
    kinases pathway, receptor activation, thromboxane A2 formation, and activation
    of key enzymes such as protein kinase C. The prostaglandin, P2Y, P2X, TR, and
    TP are all seven transmembrane G-protein associated receptors. The TR and TP on
    the right present novel drug targets; their intracellular effectors are omitted
    for clarity. Antiplatelet drugs are shown in red.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PLCB3
  - PLCD3
  - PLCB2
  - ADCY6
  - ADCY2
  - PRKAR1A
  - ADCY7
  - PLCZ1
  - PRKACG
  - ADCY4
  - PLCB4
  - ADCY8
  - ADCY9
  - ADCY1
  - ADCY5
  - MAPK13
  - ADCY3
  - MAPK8
  - IRS1
  - PLCB1
  - MAPK12
  - PLCG1
  - PLCG2
  - AGER
  - PLCD1
  - GPR162
  - GC
  - PRKACA
  - PRKAR2A
  - MAPK10
  - MAPK11
  - MAPK3
  - P2RY12
  - PLCE1
  - PRKAR1B
  - PRKACB
  - PLCD4
  - ADCY10
  - VASP
  - PRKAR2B
  - MAPK14
  - MAPK9
  - MAPK1
  - AKT1
  - WDTC1
  - Arachidonic acid
  - Thromboxane
genes:
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB3
  entrez: '5331'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD3
  entrez: '113026'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB2
  entrez: '5330'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY6
  entrez: '112'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY2
  entrez: '108'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY7
  entrez: '113'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCZ1
  entrez: '89869'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY4
  entrez: '196883'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB4
  entrez: '5332'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY8
  entrez: '114'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY9
  entrez: '115'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY1
  entrez: '107'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY5
  entrez: '111'
- word: PKB/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY3
  entrez: '109'
- word: PKB/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: IRS-1
  symbol: IRS1
  source: hgnc_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB1
  entrez: '23236'
- word: PKB/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCG1
  entrez: '5335'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCG2
  entrez: '5336'
- word: RAGE
  symbol: RAGE
  source: hgnc_alias_symbol
  hgnc_symbol: AGER
  entrez: '177'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD1
  entrez: '5333'
- word: A2
  symbol: A-2
  source: hgnc_alias_symbol
  hgnc_symbol: GPR162
  entrez: '27239'
- word: GC
  symbol: GC
  source: hgnc_symbol
  hgnc_symbol: GC
  entrez: '2638'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: PKB/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: PKB/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: PKB/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: P2Y12
  symbol: P2Y12
  source: hgnc_alias_symbol
  hgnc_symbol: P2RY12
  entrez: '64805'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCE1
  entrez: '51196'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD4
  entrez: '84812'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY10
  entrez: '55811'
- word: VASP
  symbol: VASP
  source: hgnc_symbol
  hgnc_symbol: VASP
  entrez: '7408'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: PKB/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: PKB/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: PKB/MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PKB/MAPK
  symbol: PKB
  source: hgnc_alias_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: ADP
  symbol: ADP
  source: hgnc_alias_symbol
  hgnc_symbol: WDTC1
  entrez: '23038'
chemicals:
- word: Arachidonic acid
  source: MESH
  identifier: D001095
- word: Thromboxane
  source: MESH
  identifier: D013931
diseases: []
---
